Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
06/01/2011 | EP2099796B1 Aza-indolyl compounds and methods of use |
06/01/2011 | DE102010042864A1 Substituierte Thioamide mit herbizider Wirkung Substituted thioamides with herbicidal activity |
06/01/2011 | DE102010038714A1 Composition, useful for coloring keratin fibers, preferably human hair, comprises a cationic 1-(3-amino-benzyl)-4-aza-1-azonia-bicyclo( 2.2.2)octane phenylamine compound as developer component, in a carrier |
06/01/2011 | CN1968753B Shaped body containing a microporous material and at least one silicon-containing binder, method for the production thereof and its use as a catalyst, particularly in a method for producing triethylen |
06/01/2011 | CN102083834A 7H-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c |
06/01/2011 | CN102083833A Substituted quinazolines as blood platelet lowering agents |
06/01/2011 | CN102083814A Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
06/01/2011 | CN102083800A Heteroaryl compounds and uses thereof |
06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
06/01/2011 | CN101633675B Preparation and application of 5-substituent group-6-substituent phenyl-2-ferrocenyl pyrazolo [1, 5-a] pyrazine-4(5H)-ketone derivative |
06/01/2011 | CN101525337B Oxidative desulfurization catalysts binuclear/trinuclear cobalt phthalocyanine carboxylate and preparation methods thereof |
06/01/2011 | CN101407489B 2-alkyl acrylate compounds and uses thereof |
06/01/2011 | CN101314603B Valine protected imidazo-[1,2-a] purine three-loop base opened-loop nucleoside compounds, preparation method and application thereof |
05/31/2011 | US7951958 Imidazole compounds for the treatment of neurodegenerative disorders |
05/31/2011 | US7951941 Process for preparing 5-alkyl-7H-pyrrolo[2,3-d] pyrimindine-2-ols |
05/31/2011 | US7951939 Methods and intermediates for the synthesis of porphyrins |
05/31/2011 | US7951938 Fluorinated dyes or colorants and their uses |
05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
05/31/2011 | US7951812 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007) |
05/31/2011 | US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group |
05/31/2011 | US7951810 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes |
05/31/2011 | US7951809 Inhibitors of p38 |
05/31/2011 | US7951804 Inhibitors of coagulation factors; Thrombosis, tumors, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis; example, 1-(4-chlorophenyl)-3-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-phenylethyl]urea |
05/31/2011 | US7951799 Lactam compound, a method for producing the same, and a diabetic therapy by administering the same |
05/31/2011 | US7951791 Amino-substituted tricyclic derivatives and methods of use |
05/31/2011 | CA2634299C Process for preparing inhibitors of nucleoside metabolism |
05/31/2011 | CA2501365C Inhibitors of akt activity |
05/31/2011 | CA2497450C Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
05/31/2011 | CA2480470C Inhibitors of nucleoside phosphorylases and nucleosidases |
05/31/2011 | CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use |
05/31/2011 | CA2429629C Ligand and complex for catalytically bleaching a substrate |
05/31/2011 | CA2319080C Multivalent antibacterial agents |
05/27/2011 | CA2686584A1 Plasmodium proteases inhibitors and in silico screening methods for identifying the same |
05/26/2011 | WO2011062766A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
05/26/2011 | WO2011062253A1 Novel fused pyrimidine derivative |
05/26/2011 | WO2011061679A1 Imidazo-pyrazoles as gpr119 inhibitors |
05/26/2011 | WO2011039459A3 Suspensions of hexanitrohexaazaisowurtzitane crystals, production of said suspensions and production of pyrotechnic objects |
05/26/2011 | WO2011028829A3 Organic electronic devices and polymers, including photovoltaic cells and diketone-based and diketopyrrolopyrrole-based polymers |
05/26/2011 | WO2011028827A3 Organic electronic devices and polymers, including photovoltaic cells and diketone-based polymers |
05/26/2011 | WO2011011186A3 Hdac inhibitors and therapeutic methods using the same |
05/26/2011 | US20110126300 High Through-Put Method of Screening Compounds for Pharmacological Activity |
05/26/2011 | US20110124869 Process for Preparing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
05/26/2011 | US20110124862 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
05/26/2011 | US20110124861 Process for Preparing Pemetrexed Disodium and Its Intermediate, 4-(4-Carbomethoxyphenyl) Butanal |
05/26/2011 | US20110124641 Benzothiazole kinase inhibitors and methods of use |
05/26/2011 | US20110124640 Fused heterocyclic compounds useful as kinase modulators |
05/26/2011 | US20110124634 Bioactive compounds for treatment of cancer and neurodegenerative diseases |
05/26/2011 | US20110124623 Pyrrolotriazine kinase inhibitors |
05/26/2011 | US20110124622 Isoindolones derivatives as mek kinase inhibitors and methods of use |
05/26/2011 | US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
05/26/2011 | DE102009053836A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent |
05/26/2011 | CA2781287A1 Compounds and methods for kinase modulation, and indications therefor |
05/26/2011 | CA2780463A1 Imidazo-pyrazoles as gpr119 inhibitors |
05/26/2011 | CA2780287A1 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
05/25/2011 | EP2325186A2 Fused Bicyclic mTor Inhibitors |
05/25/2011 | EP2325169A2 Lisofylline analogues and their pharmeacuetical uses |
05/25/2011 | EP2324030A1 Explosive |
05/25/2011 | EP2324029A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
05/25/2011 | EP2324028A2 Therapeutic agents 414 |
05/25/2011 | EP2324027A2 New crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4- triazolo[4,3-a]pyrazine derivative |
05/25/2011 | EP2324022A1 Substituted naphthyridines and use thereof as medicines |
05/25/2011 | EP2324021A1 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
05/25/2011 | EP2324020A2 Piperidine derivatives as jak3 inhibitors |
05/25/2011 | EP2323987A1 N-myristoyl transferase inhibitors |
05/25/2011 | EP2323981A1 Process for the preparation of a macrocycle |
05/25/2011 | EP2323665A1 Fused heterocyclic compounds useful as kinase modulators |
05/25/2011 | EP2323663A1 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines |
05/25/2011 | EP2212297B1 Inhibitors of protein kinases |
05/25/2011 | EP2125748B1 Acylaminopyrazoles as fgfr inhibitors |
05/25/2011 | CN1930166B 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and compositions containing said compounds |
05/25/2011 | CN1832938B N-heterocyclyl phenyl-substituted cyclic ketoenols |
05/25/2011 | CN1771231B Calcium receptor modulating compound and use thereof |
05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
05/25/2011 | CN102076698A 2h- pyrimido [2, 1-b] quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents |
05/25/2011 | CN102076697A Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
05/25/2011 | CN102076696A Substituted quinazolines |
05/25/2011 | CN102076695A Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases |
05/25/2011 | CN102076694A 5, 6, 7, 8-tetrahydro-imidazo[1, 5-a]pyrazine compounds |
05/25/2011 | CN102076693A Substituted tricyclic derivatives against neurodegenerative diseases |
05/25/2011 | CN102076692A Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonists |
05/25/2011 | CN102076691A Protein kinase inhibitors |
05/25/2011 | CN102076690A Protein kinase inhibitors |
05/25/2011 | CN102076689A Pyrazolo-quinazolines |
05/25/2011 | CN102076687A Substituted quinazolines as blood platelet lowering agents |
05/25/2011 | CN102076680A Benzoimidazoles as prolyl hydroxylase inhibitors |
05/25/2011 | CN102070642A Novel method for directly synthesizing cobalt phthalocyanine crystals |
05/25/2011 | CN102070641A Monosubstituted metal phthalocyanine and synthesis and separation method and application thereof |
05/25/2011 | CN102070640A Method for synthesizing 1,7-diazaspiro[4.5]nonane and derivatives thereof |
05/25/2011 | CN102070639A Method for synthesizing temozolomide |
05/25/2011 | CN102070638A Preparation method of hexahydro-pyrrolo [3,4-c] pyrrole-1-ketone derivative |
05/25/2011 | CN102068436A Dihydroporphin photosensitizer and preparation and application thereof |
05/25/2011 | CN102068428A Dihydroporphin photosensitizer and preparation and application thereof |
05/25/2011 | CN101560214B 4-amino-6-phenyl-pyrrolo[2, 3-d]pyrimidine derivatives |
05/25/2011 | CN101160308B Pharmacetically acceptable salt with decoquinate ketone compound with improved medicine performance |
05/25/2011 | CN101133055B MELEIMId derivative for treating cancer, compositions and methods |
05/24/2011 | US7947844 One-pot synthesis of benzisoindolenines used in the preparation of naphthalocyanines |
05/24/2011 | US7947829 Method of making porphyrins |
05/24/2011 | US7947827 Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use |
05/24/2011 | US7947826 Wet film filming |
05/24/2011 | US7947825 Process for making titanyl phthalocyanine |